moisturizers, should be considered for their adjunctive role
in the armamentarium of acne treatment and maintenance
strategies for Asian patients.
DISCLOSURES
The authors disclosed receipt of an unrestricted educational grant from CeraVe International for support with this work’s research. The authors also received consultancy fees for their work on this project.
All authors contributed to the development and review of this work and agreed with the content.
All authors contributed to the development and review of this work and agreed with the content.
REFERENCES
1. Rocha M, Sanudo A, Bagatin E. The effect on acne quality of life of topical azelaic acid 15% gel versus a combined oral contraceptive in adult female acne: A randomized trial. Dermatoendocrinol. 2017;9(1):e1361572.
2. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474-85.
3. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163- 96.
4. Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172 Suppl 1:3-12.
5. Rocha MA, Bagatin E. Adult-onset acne: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2018;11:59-69.
6. Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527-34.
7. Gieler U, Gieler T, Kupfer JP. Acne and quality of life - impact and management. J Eur Acad Dermatol Venereol. 2015;29 Suppl 4:12-4.
8. Walker N, Lewis-Jones MS. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). J Eur Acad Dermatol Venereol. 2006;20(1):45-50.
9. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37.
10. Dreno B, Thiboutot D, Gollnick H, et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010;49(4):448-56.
11. Pawin H, Beylot C, Chivot M, et al. Creation of a tool to assess adherence to treatments for acne. Dermatology. 2009;218(1):26-32. 12. Francis NA, Entwistle K, Santer M, Layton AM, Eady EA, Butler CC. The management of acne vulgaris in primary care: a cohort study of consulting and prescribing patterns using the Clinical Practice Research Datalink. Br J Dermatol. 2017;176(1):107-15.
13. Angelova-Fischer I, Rippke F, Fischer TW, Neufang G, Zillikens D. A doubleblind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne. J Eur Acad Dermatol Venereol. 2013;27 Suppl 2:6-11.
14. Enshaieh S, Jooya A, Siadat AH, Iraji F. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebocontrolled study. Indian J Dermatol Venereol Leprol. 2007;73(1):22-5.
15. Abad-Casintahan F, Chow SK, Goh CL, et al. Toward evidence-based practice in acne: consensus of an Asian Working Group. J Dermatol. 2011;38(11):1041-8.
16. Sturm-O'Brien AK, Brissett AE, Brissett AE. Ethnic trends in facial plastic surgery. Facial Plast Surg. 2010;26(2):69-74.
17. Ho SG, Chan HH. The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol. 2009;10(3):153-68.
18. Suh DH, Shin JW, Min SU, et al. Treatment-seeking behaviors and related epidemiological features in Korean acne patients. J Korean Med Sci. 2008;23(6):969-74.
19. Aramaki J, Kawana S, Effendy I, Happle R, Loffler H. Differences of skin irritation between Japanese and European women. Br J Dermatol. 2002;146(6):1052-6.
20. Choi JM, Lew VK, Kimball AB. A single-blinded, randomized, controlled clinical trial evaluating the effect of face washing on acne vulgaris. Pediatr Dermatol. 2006;23(5):421-7.
21. Choi YS, Suh HS, Yoon MY, et al. A study of the efficacy of cleansers for acne vulgaris. J Dermatolog Treat. 2010;21(3):201-5.
22. Dreno B, Bensadoun RJ, Humbert P, et al. Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology. J Eur Acad Dermatol Venereol. 2013;27(9):1071-80.
23. Goh CL, Noppakun N, Micali G, et al. Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy. J Cutan Aesthet Surg. 2016;9(2):85-92.
24. Draelos ZD. The art and science of new advances in cosmeceuticals. Clin Plast Surg. 2011;38(3):397-407, vi.
25. Peirano RI, Hamann T, Dusing HJ, et al. Topically applied L-carnitine effectively reduces sebum secretion in human skin. J Cosmet Dermatol. 2012;11(1):30-6.
26. Chularojanamontri L, Tuchinda P, Kulthanan K, Varothai S, Winayanuwattikun W. A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel. J Dermatolog Treat. 2016;27(2):140-5.
27. Thiboutot D, Del Rosso JQ. Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier? J Clin Aesthet Dermatol. 2013;6(2):18-24.
28. Lynde C, Tan J, Andriessen A, et al. Clinical Insights About the Role of pH in acne. J Drugs Dermatol. 2019;18(12):221.
29. Lain E, Andriessen AE. Choosing the Right Partner: Complementing Prescription Acne Medication With Over-the-Counter Cleansers and Moisturizers. J Drugs Dermatol. 2020;19(11):1069-75.
30. Cheng CE, Irwin B, Mauriello D, Liang L, Pappert A, Kimball AB. Self-reported acne severity, treatment, and belief patterns across multiple racial and ethnic groups in adolescent students. Pediatr Dermatol. 2010;27(5):446-52.
31. Pawin H, Chivot M, Beylot C, et al. Living with acne. A study of adolescents' personal experiences. Dermatology. 2007;215(4):308-14.
32. Feldman SR, Chen DM. How patients experience and manage dryness and irritation from acne treatment. J Drugs Dermatol. 2011;10(6):605-8.
33. Munehiro A, Murakami Y, Shirahige Y, et al. Combination effects of cosmetic moisturisers in the topical treatment of acne vulgaris. J Dermatolog Treat. 2012;23(3):172-6.
34. Hayashi N, Kawashima M. Study of the usefulness of moisturizers on adherence of acne patients treated with adapalene. J Dermatol. 2014;41(7):592-7.
35. Matsunaga K, Leow YH, Chan R, Kerrouche N, Paliargues F. Adjunctive usage of a non-comedogenic moisturizer with adapalene gel 0.1% improves local tolerance: a randomized, investigator-blinded, split-face study in healthy Asian subjects. J Dermatolog Treat. 2013;24(4):278-82.
36. Chularojanamontri L, Tuchinda P, Kulthanan K, Pongparit K. Moisturizers for Acne: What are their Constituents? J Clin Aesthet Dermatol. 2014;7(5):36-44.
37. Bikowski J. The use of therapeutic moisturizers in various dermatologic disorders. Cutis. 2001;68(5 Suppl):3-11.
38. Angelova-Fischer I, Rippke F, Peirano RI, Hamann T, Dusing HJ, et al. Topically applied L-carnitine effectively reduces sebum secretion in human skin. J Cosmet Dermatol. 2012;11:30–6.
39. Andriessen A, Rodas Diaz AC, Gameros PC, Macias O, Neves JR, Gonzalez CG. Over the Counter Products for Acne Treatment and Maintenance in Latin America: A Review of Current Clinical Practice. J Drugs Dermatol. 2021;20(3):244-50.
2. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474-85.
3. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163- 96.
4. Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172 Suppl 1:3-12.
5. Rocha MA, Bagatin E. Adult-onset acne: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2018;11:59-69.
6. Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527-34.
7. Gieler U, Gieler T, Kupfer JP. Acne and quality of life - impact and management. J Eur Acad Dermatol Venereol. 2015;29 Suppl 4:12-4.
8. Walker N, Lewis-Jones MS. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). J Eur Acad Dermatol Venereol. 2006;20(1):45-50.
9. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37.
10. Dreno B, Thiboutot D, Gollnick H, et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol. 2010;49(4):448-56.
11. Pawin H, Beylot C, Chivot M, et al. Creation of a tool to assess adherence to treatments for acne. Dermatology. 2009;218(1):26-32. 12. Francis NA, Entwistle K, Santer M, Layton AM, Eady EA, Butler CC. The management of acne vulgaris in primary care: a cohort study of consulting and prescribing patterns using the Clinical Practice Research Datalink. Br J Dermatol. 2017;176(1):107-15.
13. Angelova-Fischer I, Rippke F, Fischer TW, Neufang G, Zillikens D. A doubleblind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne. J Eur Acad Dermatol Venereol. 2013;27 Suppl 2:6-11.
14. Enshaieh S, Jooya A, Siadat AH, Iraji F. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebocontrolled study. Indian J Dermatol Venereol Leprol. 2007;73(1):22-5.
15. Abad-Casintahan F, Chow SK, Goh CL, et al. Toward evidence-based practice in acne: consensus of an Asian Working Group. J Dermatol. 2011;38(11):1041-8.
16. Sturm-O'Brien AK, Brissett AE, Brissett AE. Ethnic trends in facial plastic surgery. Facial Plast Surg. 2010;26(2):69-74.
17. Ho SG, Chan HH. The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol. 2009;10(3):153-68.
18. Suh DH, Shin JW, Min SU, et al. Treatment-seeking behaviors and related epidemiological features in Korean acne patients. J Korean Med Sci. 2008;23(6):969-74.
19. Aramaki J, Kawana S, Effendy I, Happle R, Loffler H. Differences of skin irritation between Japanese and European women. Br J Dermatol. 2002;146(6):1052-6.
20. Choi JM, Lew VK, Kimball AB. A single-blinded, randomized, controlled clinical trial evaluating the effect of face washing on acne vulgaris. Pediatr Dermatol. 2006;23(5):421-7.
21. Choi YS, Suh HS, Yoon MY, et al. A study of the efficacy of cleansers for acne vulgaris. J Dermatolog Treat. 2010;21(3):201-5.
22. Dreno B, Bensadoun RJ, Humbert P, et al. Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology. J Eur Acad Dermatol Venereol. 2013;27(9):1071-80.
23. Goh CL, Noppakun N, Micali G, et al. Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy. J Cutan Aesthet Surg. 2016;9(2):85-92.
24. Draelos ZD. The art and science of new advances in cosmeceuticals. Clin Plast Surg. 2011;38(3):397-407, vi.
25. Peirano RI, Hamann T, Dusing HJ, et al. Topically applied L-carnitine effectively reduces sebum secretion in human skin. J Cosmet Dermatol. 2012;11(1):30-6.
26. Chularojanamontri L, Tuchinda P, Kulthanan K, Varothai S, Winayanuwattikun W. A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel. J Dermatolog Treat. 2016;27(2):140-5.
27. Thiboutot D, Del Rosso JQ. Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier? J Clin Aesthet Dermatol. 2013;6(2):18-24.
28. Lynde C, Tan J, Andriessen A, et al. Clinical Insights About the Role of pH in acne. J Drugs Dermatol. 2019;18(12):221.
29. Lain E, Andriessen AE. Choosing the Right Partner: Complementing Prescription Acne Medication With Over-the-Counter Cleansers and Moisturizers. J Drugs Dermatol. 2020;19(11):1069-75.
30. Cheng CE, Irwin B, Mauriello D, Liang L, Pappert A, Kimball AB. Self-reported acne severity, treatment, and belief patterns across multiple racial and ethnic groups in adolescent students. Pediatr Dermatol. 2010;27(5):446-52.
31. Pawin H, Chivot M, Beylot C, et al. Living with acne. A study of adolescents' personal experiences. Dermatology. 2007;215(4):308-14.
32. Feldman SR, Chen DM. How patients experience and manage dryness and irritation from acne treatment. J Drugs Dermatol. 2011;10(6):605-8.
33. Munehiro A, Murakami Y, Shirahige Y, et al. Combination effects of cosmetic moisturisers in the topical treatment of acne vulgaris. J Dermatolog Treat. 2012;23(3):172-6.
34. Hayashi N, Kawashima M. Study of the usefulness of moisturizers on adherence of acne patients treated with adapalene. J Dermatol. 2014;41(7):592-7.
35. Matsunaga K, Leow YH, Chan R, Kerrouche N, Paliargues F. Adjunctive usage of a non-comedogenic moisturizer with adapalene gel 0.1% improves local tolerance: a randomized, investigator-blinded, split-face study in healthy Asian subjects. J Dermatolog Treat. 2013;24(4):278-82.
36. Chularojanamontri L, Tuchinda P, Kulthanan K, Pongparit K. Moisturizers for Acne: What are their Constituents? J Clin Aesthet Dermatol. 2014;7(5):36-44.
37. Bikowski J. The use of therapeutic moisturizers in various dermatologic disorders. Cutis. 2001;68(5 Suppl):3-11.
38. Angelova-Fischer I, Rippke F, Peirano RI, Hamann T, Dusing HJ, et al. Topically applied L-carnitine effectively reduces sebum secretion in human skin. J Cosmet Dermatol. 2012;11:30–6.
39. Andriessen A, Rodas Diaz AC, Gameros PC, Macias O, Neves JR, Gonzalez CG. Over the Counter Products for Acne Treatment and Maintenance in Latin America: A Review of Current Clinical Practice. J Drugs Dermatol. 2021;20(3):244-50.
AUTHOR CORRESPONDENCE
Anneke Andriessen anneke.a@tiscali.nl
